<Disease><Name>MUCOPOLYSACCHARIDOSIS IV; MORQUIO A SYNDROME</Name><Synonym>MPS4A</Synonym><OMIM><Number>253000</Number><URL>http://omim.org/entry/253000</URL></OMIM><Orphanet><Number>309297</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=309297</URL></Orphanet><Protein><Number>N-acetylgalactosamine-6-sulfatase</Number><URL>http://www.uniprot.org/uniprot/P34059</URL></Protein><ExPASy><Number>3.1.6.4</Number><URL>http://enzyme.expasy.org/EC/3.1.6.4</URL></ExPASy><Gene>16q24.3Detail information to gene locus by the National Center for Biotechnology Information NCBI:

Galactosamine (N-acetyl)-6-sulfate sulfatase
</Gene><ICD>E76.2</ICD><Summary>rare (1:300000);autosomal recessive ;MUCOPOLYSACCHARIDOSIS IV:;Type A: severe form ;Type B: milder form</Summary><Symptoms><symtomp><id>3931</id><symptom>chest deformity / pectus carinatum/excavatum, starnal bulging</symptom><category>BODY</category></symtomp><symtomp><id>1761</id><symptom>coarse facial features</symptom><category>HEAD</category></symtomp><symtomp><id>2448</id><symptom>corneal clouding</symptom><category>EYES</category></symtomp><symtomp><id>2124</id><symptom>corneal deposits</symptom><category>EYES</category></symtomp><symtomp><id>1845</id><symptom>dental caries</symptom><category>HEAD</category></symtomp><symtomp><id>3245</id><symptom>dwarfism</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2302</id><symptom>dysostosis multiplex</symptom><category>SKELATAL DEFECT</category></symtomp><symtomp><id>3929</id><symptom>genu valgum / genua valga</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2356</id><symptom>hydrops fetalis</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>1853</id><symptom>hypoplastic enamel (thin)</symptom><category>HEAD</category></symtomp><symtomp><id>1715</id><symptom>infections (severe or recurrent)</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>1910</id><symptom>inguinal hernia</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2620</id><symptom>joint hypermobilty, dislocations, laxity</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>3930</id><symptom>joint laxity</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1786</id><symptom>myopathy</symptom><category>MUSCLES</category></symtomp><symtomp><id>2340</id><symptom>normal at birth</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2127</id><symptom>osteoporosis</symptom><category>SKELATAL DEFECT</category></symtomp><symtomp><id>2311</id><symptom>prominent lower face</symptom><category>HEAD</category></symtomp><symtomp><id>3800</id><symptom>restrictive lung disease</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1832</id><symptom>short neck</symptom><category>BODY</category></symtomp><symtomp><id>2109</id><symptom>short stature</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2310</id><symptom>short trunk</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2342</id><symptom>skeletal changes, skeletal abnormalities</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>2250</id><symptom>skoliosis, kyphoskoliosis</symptom><category>BODY | SKELATAL DEFECT</category></symtomp><symtomp><id>1859</id><symptom>Teeth: generalized defect or abnormalities</symptom><category>HEAD</category></symtomp><symtomp><id>2355</id><symptom>valvular heart disease</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2447</id><symptom>vertebral changes or anomalies</symptom><category>BODY | SKELATAL DEFECT</category></symtomp><symtomp><id>3932</id><symptom>voice alterations</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>2248</id><symptom>X-ray, abnormalities</symptom><category>LABORATORY FINDINGS</category></symtomp></Symptoms><Metabolites><metabolite><id>901</id><name>N-Acetylgalactosamin-6-sulfate sulfatase</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7374</id><title>Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns</title><author>Chien YH,</author><journal>Orphanet J Rare Dis</journal><year>2020</year><book /><volume>15</volume><number>1</number><pages>38</pages><co_aut>et al.</co_aut></literature><literature><id>7375</id><title>A Case Report of a Japanese Boy with Morquio A Syndrome: Effects of Enzyme Replacement Therapy Initiated at the Age of 24 Month</title><author>Nakamura-Utsunomiya A,</author><journal>Int J Mol Sci</journal><year>2020</year><book /><volume>21</volume><number>3</number><pages>E989</pages><co_aut>et al.</co_aut></literature><literature><id>7988</id><title>Screening for Carpal Tunnel Syndrome in Patients With Mucopolysaccharidosis</title><author>Patel P,</author><journal>J Child Neurol</journal><year>2020</year><book /><volume>35</volume><number>6</number><pages>410-417</pages><co_aut>et al.</co_aut></literature><literature><id>7376</id><title>Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model</title><author>Sawamoto K,</author><journal>Int J Mol Sci</journal><year>2019</year><book /><volume>20</volume><number>17</number><pages>E4139</pages><co_aut>Tomatsu S</co_aut></literature><literature><id>7377</id><title>Mutation spectrum and pivotal features for differential diagnosis of Mucopolysaccharidosis IVA patients with severe and attenua</title><author>T&#252;ys&#252;z B,</author><journal>Gene</journal><year>2019</year><book /><volume>170</volume><number>0</number><pages>59-67</pages><co_aut>et al.</co_aut></literature><literature><id>7378</id><title>Effect of enzyme replacement therapy on the growth of patients with Morquio A</title><author>Doherty C,</author><journal>J Hum Genet</journal><year>2019</year><book /><volume>64</volume><number>7</number><pages>625-635</pages><co_aut>et al.</co_aut></literature><literature><id>7379</id><title>Novel data on growth phenotype and causative genotypes in 29 patients with Morquio (Morquio-Brailsford) syndrome from Central-Eastern Europe</title><author>Jezela-Stanek A,</author><journal>J Appl Genet</journal><year>2019</year><book /><volume>60</volume><number>2</number><pages>163-174</pages><co_aut>et al.</co_aut></literature><literature><id>6152</id><title>Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA</title><author>Peracha H,</author><journal>Mol Genet Metab</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6153</id><title>Voice alterations in patients with Morquio A syndrome</title><author>Szklanny K,</author><journal>J Appl Genet</journal><year>2018</year><book /><volume>59</volume><number>1</number><pages>73-80</pages><co_aut>Gubrynowicz R, Tylki-Szyma&#324;ska A</co_aut></literature><literature><id>4823</id><title>Elosulfase alfa (BMN 110) for the treatment of mucopolysaccharidosis IVA (Morquio A Syndrome)</title><author>Hendriksz CJ</author><journal>Expert Rev Clin Pharmacol</journal><year>2016</year><book /><volume>9</volume><number>12</number><pages>1521-1532</pages><co_aut /></literature><literature><id>4824</id><title>Role of elosulfase alfa in mucopolysaccharidosis IVA</title><author>Regier DS,</author><journal>Appl Clin Genet</journal><year>2016</year><book /><volume>9</volume><number>0</number><pages>67-74</pages><co_aut>Tanpaiboon P</co_aut></literature><literature><id>4825</id><title>Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome</title><author>Tomatsu S,</author><journal>Drug Des Devel Ther</journal><year>2015</year><book /><volume>9</volume><number>0</number><pages>1937-1953</pages><co_aut>et al.</co_aut></literature><literature><id>4826</id><title>International guidelines for the management and treatment of Morquio A syndrome</title><author>Hendriksz CJ,</author><journal>Am J Med Genet A</journal><year>2015</year><book /><volume>167</volume><number>1</number><pages>11-25</pages><co_aut>et al.</co_aut></literature><literature><id>4831</id><title>Di-sulfated Keratan Sulfate as a Novel Biomarker for Mucopolysaccharidosis II, IVA, and IVB</title><author>Shimada T,</author><journal>JIMD Rep</journal><year>2015</year><book /><volume>21</volume><number>0</number><pages>1-13</pages><co_aut>et al.</co_aut></literature><literature><id>4827</id><title>A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases</title><author>Leadley RM,</author><journal>Orphanet J Rare Dis</journal><year>2014</year><book /><volume>9</volume><number>0</number><pages>173</pages><co_aut>et al.</co_aut></literature><literature><id>4828</id><title>Morquio A syndrome-associated mutations: a review of alterations in the GALNS gene and a new locus-specific database</title><author>Morrone A,</author><journal>Hum Mutat</journal><year>2014</year><book /><volume>35</volume><number>11</number><pages>1271-1279</pages><co_aut>et al.</co_aut></literature><literature><id>4829</id><title>Morquio A syndrome: diagnosis and current and future therapies</title><author>Tomatsu S,</author><journal>Pediatr Endocrinol Rev Suppl</journal><year>2014</year><book /><volume>1</volume><number>0</number><pages>141-151</pages><co_aut>et al.</co_aut></literature><literature><id>6150</id><title>A new lysosomal storage disorder resembling Morquio syndrome in sibs</title><author>Perrin L,</author><journal>Eur J Med Genet</journal><year>2012</year><book /><volume>55</volume><number>3</number><pages>157-162</pages><co_aut>et al.</co_aut></literature><literature><id>2715</id><title>International Morquio A Registry: clinical manifestation and natural course of Morquio A disease</title><author>Montano AM</author><journal>J Inher Met Dis</journal><year>2007</year><book /><volume>30</volume><number>0</number><pages>165-174</pages><co_aut>et al.</co_aut></literature><literature><id>1799</id><title>Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy</title><author>Meikle PJ</author><journal>Pediatrics</journal><year>2004</year><book /><volume>114</volume><number>4</number><pages>909-916</pages><co_aut>et al.</co_aut></literature><literature><id>2245</id><title>Mucopolysaccharidosis IVA (Morquio A): identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatas</title><author>Tomatsu S</author><journal>Hum Mutat</journal><year>2004</year><book /><volume>24</volume><number>2</number><pages>187-188</pages><co_aut>et al.</co_aut></literature><literature><id>2246</id><title>Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA</title><author>Tomatsu S</author><journal>Pediatr Res</journal><year>2004</year><book /><volume>55</volume><number>4</number><pages>592-597</pages><co_aut>et al.</co_aut></literature><literature><id>102</id><title>The mucopolysaccharidoses</title><author>Neufeld EF</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2465-2494</pages><co_aut>M&#252;nzer J</co_aut></literature></Literatures></Disease>